PBA
SRRA

Paradigm Biocapital Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Paradigm Biocapital Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-801,314
Closed -$44.1M – 32
2022
Q2 		$44.1M Buy
801,314
+30,000
+4% +$1.65M 8.79% 4
2022
Q1 		$24.7M Buy
771,314
+296,369
+62% +$9.5M 6.54% 5
2021
Q4 		$10.3M Buy
+474,945
New +$10.3M 2.95% 14